ACETAMINOPHEN; CODEINE PHOSPHATE | A202800 | AUROLIFE PHARMA LLC
Highest NADAC/Unit
$0.3809
per ea
Lowest NADAC/Unit
$0.2432
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 13107006001ACETAMINOPHEN-COD #4 TABLET | $0.3809 | EA | Generic | — | 2026-08-19 |
| 13107006005ACETAMINOPHEN-COD #4 TABLET | $0.3809 | EA | Generic | — | 2026-08-19 |
| 13107006099ACETAMINOPHEN-COD #4 TABLET | $0.3809 | EA | Generic | — | 2026-08-19 |
| 13107005801ACETAMINOPHEN-COD #2 TABLET | $0.2757 | EA | Generic | — | 2026-08-19 |
| 13107005901ACETAMINOPHEN-COD #3 TABLET | $0.2432 | EA | Generic | — | 2026-08-19 |
| 13107005999ACETAMINOPHEN-COD #3 TABLET | $0.2432 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.